Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Damion Boyer
COO
damion@corvidane.com

Message the company or request a 1:1 meeting here

Corvidane is using a novel approach to develop one drug capable of addressing the two leading causes of death and the leading cause of liver transplants.

Following early development, Corvidane plans to sell or license Corvida™ within 5 years.

Pitch Video

Slide Deck

Executive Summary